These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeted drug delivery to mammalian mitochondria in living cells. Weissig V Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737 [TBL] [Abstract][Full Text] [Related]
4. The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery? Zorzano A; Sebastián D; Segalés J; Palacín M Curr Opin Drug Discov Devel; 2009 Sep; 12(5):597-606. PubMed ID: 19736619 [TBL] [Abstract][Full Text] [Related]
5. Mitophagy in neurodegeneration: an opportunity for therapy? Santos RX; Correia SC; Carvalho C; Cardoso S; Santos MS; Moreira PI Curr Drug Targets; 2011 Jun; 12(6):790-9. PubMed ID: 21269269 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria as a therapeutic target for common pathologies. Murphy MP; Hartley RC Nat Rev Drug Discov; 2018 Dec; 17(12):865-886. PubMed ID: 30393373 [TBL] [Abstract][Full Text] [Related]
10. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Esteves AR; Gozes I; Cardoso SM Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives. Park JS; Davis RL; Sue CM Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350 [TBL] [Abstract][Full Text] [Related]
12. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease. Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653 [TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model. Jia H; Liu Z; Li X; Feng Z; Hao J; Li X; Shen W; Zhang H; Liu J Neurobiol Aging; 2010 Apr; 31(4):636-46. PubMed ID: 18639366 [TBL] [Abstract][Full Text] [Related]
14. Development of pharmacological strategies for mitochondrial disorders. Kanabus M; Heales SJ; Rahman S Br J Pharmacol; 2014 Apr; 171(8):1798-817. PubMed ID: 24116962 [TBL] [Abstract][Full Text] [Related]